Home » Healthcare » Pharmaceuticals » Vitamins, Minerals, and Supplements CDMO Market

Vitamins, Minerals, and Supplements CDMO Market By Type (Vitamins, Minerals, Dietary Supplements, Others); By Dosage Form (Tablets & Capsules, Powder, Softgel, Others); By Service Type (Product Formulation and Development, Manufacturing and Packaging, Research & Development (R\&D), Regulatory Compliance, Others); By Company Size (Small Companies, Mid-Sized Companies, Large Companies) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

Market Overview

The Vitamins, Minerals, and Supplements CDMO market size was valued at USD 23,662.63 million in 2018, increased to USD 38,800.18 million in 2024, and is anticipated to reach USD 76,410.24 million by 2032, at a CAGR of 8.23% during the forecast period.

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Vitamins, Minerals, and Supplements CDMO Market Size 2024	USD 38,800.18 million
Vitamins, Minerals, and Supplements CDMO Market, CAGR	8.23%
Vitamins, Minerals, and Supplements CDMO Market Size 2032	USD 76,410.24 million

The Vitamins, Minerals, and Supplements CDMO market is led by prominent players such as Catalent Inc., Lonza Group AG, Aenova Group, NutraScience Labs, CAPTEK Softgel International Inc., Alkemist Labs, and Ashland Global Holdings. These companies maintain a competitive edge through robust manufacturing capabilities, comprehensive service portfolios, and strategic collaborations with nutraceutical brands. Catalent and Lonza dominate due to their global reach and advanced formulation technologies, while Aenova and CAPTEK offer specialized expertise in softgel and capsule production. North America stands as the leading region in this market, accounting for 42.4% of the global revenue in 2024. The region benefits from a strong regulatory framework, high consumer health awareness, and well-established CDMO infrastructure.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The Vitamins, Minerals, and Supplements CDMO market was valued at USD 38,800.18 million in 2024 and is projected to reach USD 76,410.24 million by 2032, growing at a CAGR of 8.23% during the forecast period.
Market growth is driven by increasing consumer focus on preventive healthcare, rising demand for clean-label and plant-based supplements, and the growing trend of outsourcing manufacturing to specialized CDMOs.
Tablets & capsules dominate the dosage form segment with over 50% market share, while dietary supplements lead the type segment with a 45%+ share due to their widespread usage and consumer preference.
North America accounted for 42.4% of the global market in 2024, followed by Europe with 29.6%, and Asia Pacific with 19.9%, which is the fastest-growing region due to rising health awareness and expanding middle-class populations.
Market restraints include complex regulatory requirements, high capital investment for compliance, and raw material supply chain disruptions.

Market Segmentation Analysis:

By Type

In the Vitamins, Minerals, and Supplements CDMO market, the Dietary Supplements segment holds the dominant share, accounting for over 45% of the total market revenue in 2024. The growth is primarily driven by increasing consumer awareness regarding preventive healthcare and immunity-boosting products. Rising demand for personalized nutrition and the surge in health-conscious lifestyles further support the expansion of this segment. Additionally, the popularity of botanical and plant-based supplements, coupled with evolving fitness trends and aging populations globally, continue to drive formulation innovation and contract manufacturing partnerships in the dietary supplement segment.

For instance, Catalent Inc. reported that it manufactured over 19 billion doses of dietary supplements globally in 2023, leveraging its plant-based encapsulation technologies across 50+ product lines, significantly contributing to its leadership in the segment.

By Dosage Form

Among the dosage forms, Tablets & Capsules emerged as the leading sub-segment, commanding more than 50% market share in 2024. This dominance is attributed to their high patient compliance, longer shelf life, ease of production, and precise dosage control. Tablets and capsules remain the preferred delivery format for both consumers and manufacturers, especially in vitamin and mineral-based formulations. Moreover, advancements in encapsulation technology and extended-release mechanisms are encouraging CDMOs to expand production capabilities in this form, meeting the growing demand from brands looking for scalable and cost-effective dosage solutions.

For instance, Lonza Group AG has invested in capsule production expansions in its Greenwood, South Carolina facility, increasing its capsule output capacity by 30 billion capsules annually, with a strong focus on its DRcaps™ and Vcaps® Plus technologies for nutritional applications.

By Service Type

Within the service type category, Manufacturing and Packaging stands as the largest sub-segment, contributing approximately 40% of the overall revenue share in 2024. The segment benefits from rising outsourcing trends among nutraceutical brands seeking efficiency, scalability, and regulatory-compliant production environments. Demand for innovative packaging solutions that ensure product stability and enhance shelf appeal further drives growth. Additionally, increased regulatory scrutiny around labeling and traceability encourages brands to partner with CDMOs that offer integrated manufacturing and packaging services aligned with GMP and other international quality standards.

Market Overview

Rising Demand for Preventive Healthcare and Nutritional Awareness

Increasing consumer awareness about preventive health and wellness is a major growth driver for the Vitamins, Minerals, and Supplements CDMO market. Consumers are proactively investing in nutritional products to strengthen immunity, support aging, and manage lifestyle-related conditions. This shift is encouraging supplement brands to expand product portfolios, thereby increasing the outsourcing of development and manufacturing to CDMOs. The demand is further supported by global health campaigns, increasing self-medication practices, and the adoption of natural and plant-based supplements in daily health regimens.

For instance, Aenova Group supported the launch of over 200 new preventive health SKUs in 2023, specifically targeting immunity and cardiovascular health, manufactured across its 14 GMP-certified sites serving global clients.

Brand Outsourcing and Focus on Core Competencies

Nutraceutical brands are increasingly outsourcing production and formulation to CDMOs in order to focus on marketing, branding, and innovation. This trend is particularly strong among startups and mid-sized firms lacking the infrastructure for compliant manufacturing. CDMOs offer integrated solutions from R&D to packaging, enabling faster product launches and regulatory compliance. This strategic outsourcing allows brands to remain agile in responding to market demands while ensuring cost-efficiency and scalability, further driving CDMO market expansion.

For instance, NutraScience Labs facilitated the formulation, testing, and market launch of 150+ brand-new dietary supplements for emerging U.S. brands in 2023 alone, with average turnaround times of 10–14 business days for label compliance and pilot batch production.

Expansion of Glal Supplement Markets and E-commerce Channels

The globalization of health supplement consumption, along with the rapid growth of e-commerce platforms, is boosting demand for contract manufacturing services. Brands are leveraging digital channels to reach broader audiences across regions, which necessitates scalable production and supply chain support. CDMOs play a vital role in enabling these cross-border operations by ensuring product standardization, multilingual labeling, and regulatory adherence. This global shift in consumer behavior supports sustained market growth for CDMO providers serving vitamins, minerals, and supplements.

Key Trends & Opportunities

Adoption of Advanced Technologies and Personalized Formulations

Technological advancements such as microencapsulation, time-release coatings, and 3D printing of supplements are transforming the CDMO landscape. These innovations enable customized nutrition solutions tailored to specific demographics or health goals. CDMOs investing in such advanced capabilities attract clients seeking differentiation in an increasingly competitive market. The trend toward personalized supplements, driven by genomics and lifestyle data, offers a significant opportunity for CDMOs to provide value-added formulation and development services.

For instance, Panaceutics Nutrition has deployed 10 automated robotic production lines for customized supplement sachets based on consumer genomic data and has fulfilled over 2.3 million personalized orders in the past year across North America.

Expansion into Clean Label and Plant-Based Products

The market is witnessing a strong shift toward clean-label, organic, and plant-based supplement formulations. Consumers are demanding transparency in ingredient sourcing and manufacturing processes, prompting brands to reformulate products without artificial additives or allergens. This opens opportunities for CDMOs specializing in natural formulations and compliant production environments. CDMOs that can demonstrate sustainable practices, ethical sourcing, and certifications such as USDA Organic or Non-GMO Project Verified stand to gain a competitive edge in the evolving nutraceutical landscape.

Key Challenges

Stringent Regulatory Requirements Across Markets

One of the key challenges in the CDMO market is navigating diverse and evolving regulatory frameworks across regions. CDMOs must adhere to Good Manufacturing Practices (GMP), FDA guidelines, and other country-specific regulations, which require constant monitoring and compliance upgrades. Failure to meet regulatory standards can lead to product recalls, penalties, or loss of client trust. Ensuring consistent compliance across multiple jurisdictions is resource-intensive and demands robust quality assurance systems.

For instance, CAPTEK Softgel International Inc. successfully completed 8 consecutive FDA inspections and maintained compliance with NSF International and Health Canada certifications across all its softgel production batches, ensuring uninterrupted service to over 70 global nutraceutical brands in 2023.

Volatility in Raw Material Supply and Pricing

The availability and cost of raw materials such as herbal extracts, vitamins, and minerals are subject to global supply chain disruptions, seasonal variability, and geopolitical tensions. Price volatility can significantly impact profit margins for CDMOs working on fixed contracts. Additionally, sourcing high-quality, contaminant-free ingredients adds complexity and cost. CDMOs must implement risk management strategies and build resilient supplier networks to mitigate these disruptions and maintain production continuity.

High Capital Investment in Infrastructure and Technology

Establishing or upgrading facilities to meet international quality and safety standards involves substantial capital expenditure. Investment in R&D labs, automated equipment, and cleanroom technologies is necessary to attract high-profile clients but presents a financial burden, especially for smaller CDMOs. The need for continual investment in new technologies and certifications can limit scalability and profitability, making it difficult for emerging players to compete with established firms.

Regional Analysis

North America

North America dominated the global Vitamins, Minerals, and Supplements CDMO market in 2024, accounting for approximately 42.4% of the total revenue, with a market size of USD 16,443.91 million, up from USD 10,135.77 million in 2018. The region is projected to reach USD 32,475.11 million by 2032, growing at a CAGR of 8.3% during the forecast period. The market is driven by a strong presence of nutraceutical brands, high consumer spending on health and wellness, and advanced CDMO infrastructure. Additionally, regulatory compliance and innovation in delivery formats support the steady growth of CDMO services in this region.

For instance, Gummi World opened a 140,000 sq ft nutraceutical facility in Arizona in 2023, equipped with 14 in-house R&D labs and an annual gummy production capacity of 3 billion units, serving major U.S.-based vitamin brands.

Europe

Europe held a market share of approximately 29.6% in 2024, with a market value rising from USD 7,246.30 million in 2018 to USD 11,485.11 million in 2024, and is expected to reach USD 21,395.38 million by 2032, growing at a CAGR of 7.5%. The region’s growth is supported by stringent quality regulations, a high aging population, and increasing demand for plant-based and organic supplements. Leading CDMOs across Western Europe benefit from technologically advanced facilities and strategic collaborations with pharmaceutical and nutraceutical companies, fostering consistent expansion in the vitamin and supplement contract manufacturing landscape.

For instance, Sirio Europe operates a state-of-the-art facility in Germany that manufactures over 6 billion capsules and tablets annually, and in 2023 introduced 14 new organic-certified supplement formulas catering to the growing demand for clean-label nutraceuticals in the region.

Asia Pacific

Asia Pacific is the fastest-growing region in the Vitamins, Minerals, and Supplements CDMO market, with a CAGR of 10.0%. The market surged from USD 4,343.51 million in 2018 to USD 7,748.20 million in 2024, and is forecasted to reach USD 17,370.72 million by 2032, capturing a 19.9% market share in 2024. The growth is fueled by increasing disposable income, rising health awareness, and a rapidly expanding middle-class population in countries like China, India, and Japan. Furthermore, cost-effective manufacturing capabilities and government support for nutraceutical industries are attracting foreign investments and boosting the regional CDMO landscape.

Latin America

Latin America accounted for approximately 4.4% of the global market share in 2024, with its value increasing from USD 1,046.69 million in 2018 to USD 1,693.50 million in 2024, and is projected to reach USD 2,925.50 million by 2032, at a CAGR of 6.5%. The regional growth is supported by growing consumer interest in health and wellness, expanding pharmaceutical distribution networks, and increasing foreign investment in the nutraceutical sector. Brazil and Mexico lead the market due to their strong domestic demand and improving regulatory environment, encouraging local CDMO development and regional product expansion.

Middle East

The Middle East represented a modest 2.4% share of the global Vitamins, Minerals, and Supplements CDMO market in 2024, growing from USD 620.67 million in 2018 to USD 924.36 million in 2024, and is forecast to reach USD 1,514.72 million by 2032, at a CAGR of 5.7%. Growth in the region is influenced by rising awareness of preventive health, increased investments in healthcare infrastructure, and diversification efforts by local pharmaceutical manufacturers. The demand for halal-certified and regionally tailored supplement formulations is also expanding, creating new opportunities for CDMOs looking to penetrate niche markets within the Gulf Cooperation Council (GCC) countries.

Africa

Africa accounted for the smallest regional share in 2024, representing approximately 1.3% of the global market, with its market value rising from USD 269.68 million in 2018 to USD 505.10 million in 2024, and expected to reach USD 728.80 million by 2032, growing at a CAGR of 4.0%. The market remains at a nascent stage, but rising urbanization, increased government focus on healthcare accessibility, and the growing presence of international nutraceutical brands are fostering gradual development. Limited manufacturing capacity and regulatory complexities pose challenges, yet long-term opportunities exist as awareness around nutrition and wellness continues to improve.

Market Segmentations:

By Type

Vitamins
Minerals
Dietary Supplements
Others

By Dosage Form

Tablets & Capsules
Powder
Softgel
Others

By Service Type

Product Formulation and Development
Manufacturing and Packaging
Research & Development (R&D)
Regulatory Compliance
Others

By Company Size

Small Companies
Mid-Sized Companies
Large Companies

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Competitive Landscape

The Vitamins, Minerals, and Supplements CDMO market is moderately consolidated, with several key players competing on capabilities such as product innovation, manufacturing scale, and regulatory compliance. Leading companies such as Catalent Inc., Lonza Group AG, and Aenova Group maintain strong market positions through comprehensive service offerings, global manufacturing footprints, and strategic partnerships with nutraceutical brands. These CDMOs focus on expanding their formulation technologies and investing in advanced delivery systems to meet rising demand for customized, plant-based, and clean-label products. Smaller and mid-sized firms like NutraScience Labs and CAPTEK Softgel International Inc. differentiate through agility, niche expertise, and client-centric services. Mergers, acquisitions, and capacity expansions are frequent strategies used to gain competitive advantage. As market demand intensifies, especially from start-ups and direct-to-consumer brands, competition is expected to grow. CDMOs that align with evolving regulatory requirements, offer flexible production capabilities, and invest in innovation are best positioned to sustain long-term growth in this dynamic industry.

For instance, Catalent Inc. completed 9 strategic acquisitions between 2020 and 2023, including the $1.2 billion acquisition of Bettera Wellness, enhancing its capabilities in gummy, softgel, and powder delivery platforms tailored to the supplement market.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Catalent Inc.
Lonza Group AG
Aenova Group
NutraScience Labs
CAPTEK Softgel International Inc.
Alkemist Labs
Ashland Global Holdings

Recent Developments

In May 2025, Aenova Group launched the “Aenovation™” program—an initiative to fast-track pharmaceutical and nutritional supplement product development, with focus areas including new technologies in vitamins and minerals manufacturing.
In March 2025, Aenova Group Received the “CDMO Leadership Award 2025” in the Small Molecule Dosage Form – Global category, underlining its excellence in contract manufacturing of supplements.
In December 2024, Novo Holdings completed its acquisition of Catalent Inc. for $16.5 billion, taking the CDMO leader private. This move is anticipated to accelerate Catalent’s innovation capacity and global expansion under new ownership. Alessandro Maselli remains CEO, ensuring continuity and emphasizing Catalent’s continued focus on enabling the development and supply of consumer health solutions. Direct effects include enhanced resources for vitamins, minerals, and supplements (VMS) manufacturing.
In October 2024, CAPTEK earned prestigious NSF certifications, bolstering its reputation for quality assurance in encapsulated vitamin, mineral, and supplement manufacturing.
In September 2024, Ashland Global Holdings Completed the sale of its nutraceuticals business (which included custom formulation and contract manufacturing for supplements) to Turnspire Capital Partners, signaling an exit from the contract supplement manufacturing space. The divested businesses, now under Pharmachem Innovations, continue to serve the marketplace with proprietary ingredients and CDMO capabilities.

Market Concentration & Characteristics

The Vitamins, Minerals, and Supplements CDMO Market demonstrates moderate market concentration, with a mix of global leaders and specialized regional players competing across service types and dosage forms. Large firms such as Catalent Inc., Lonza Group AG, and Aenova Group hold significant market shares due to their integrated capabilities, advanced technologies, and global supply chains. It shows a high degree of client reliance on external manufacturing partners, particularly among emerging nutraceutical brands seeking regulatory compliance and cost efficiency. The market favors CDMOs that offer end-to-end solutions, including product development, formulation, and packaging. It remains fragmented across some regions, with local players focusing on niche formulations and flexible production models. The demand for clean-label, personalized, and plant-based supplements has strengthened competition and innovation. Entry barriers stay moderately high due to strict regulatory standards, capital requirements, and technical expertise. It requires continuous investment in quality systems, equipment upgrades, and certifications to remain competitive. Strong relationships with brand owners and the ability to scale production quickly distinguish top-performing CDMOs in this evolving landscape.

Report Coverage

The research report offers an in-depth analysis based on Type, Dosage Form, Service Type, Company Size and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The market will continue to grow steadily due to rising consumer interest in preventive healthcare and nutritional supplementation.
Demand for personalized vitamins and supplements will increase, driving innovation in formulation and delivery systems.
E-commerce expansion will enable broader market access, encouraging brands to outsource scalable production to CDMOs.
Plant-based, clean-label, and organic product lines will gain more traction, prompting CDMOs to adapt their capabilities accordingly.
Regulatory compliance will remain a key focus, requiring CDMOs to invest in quality assurance and global certification standards.
Partnerships between nutraceutical brands and CDMOs will become more strategic, with emphasis on speed-to-market and flexibility.
Technological advancements in microencapsulation and controlled-release systems will enhance product differentiation.
Emerging markets in Asia Pacific and Latin America will offer growth opportunities due to rising health awareness and purchasing power.
CDMOs that offer end-to-end integrated services will see increased demand from small and mid-sized brands.
Sustainability in packaging and sourcing practices will become a competitive differentiator for contract manufacturers.

CHAPTER NO. 1: GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2: EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3: VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

3.6 Price Trend Analysis

3.6.1 Regional Price Trend
3.6.2 Price Trend by Product

CHAPTER NO. 4: KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Product Categories

4.3 Application Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Type & Service Type Revenue

CHAPTER NO. 6: TRADE & COMMERCE ANALYSIS

6.1. Import Analysis by Region

6.1.1. Global Vitamins, Minerals, and Supplements CDMO Market Import Revenue By Region

6.2. Export Analysis by Region

6.2.1. Global Vitamins, Minerals, and Supplements CDMO Market Export Revenue By Region

CHAPTER NO. 7: COMPETITION ANALYSIS

7.1. Company Market Share Analysis

7.1.1. Global Vitamins, Minerals, and Supplements CDMO Market: Company Market Share

7.2. Global Vitamins, Minerals, and Supplements CDMO Market Company Revenue Market Share

7.3. Strategic Developments

7.3.1. Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8: VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – BY TYPE SEGMENT ANALYSIS

8.1. Vitamins, Minerals, and Supplements CDMO Market Overview by Type Segment

8.1.1. Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Type

8.2. Vitamins

8.3. Minerals

8.4. Dietary Supplements

8.5. Others

CHAPTER NO. 9: VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – BY DOSAGE FORM SEGMENT ANALYSIS

9.1. Vitamins, Minerals, and Supplements CDMO Market Overview by Dosage Form Segment

9.1.1. Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Dosage Form

9.2. Tablets & Capsules

9.3. Powder

9.4. Softgel

9.5. Others

CHAPTER NO. 10: VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – BY SERVICE TYPE SEGMENT ANALYSIS

10.1. Vitamins, Minerals, and Supplements CDMO Market Overview by Service Type Segment

10.1.1. Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Service Type

10.2. Product Formulation and Development

10.3. Manufacturing and Packaging

10.4. Research & Development (R&D)

10.5. Regulatory Compliance

10.6. Others

CHAPTER NO. 11: VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – BY COMPANY SIZE SEGMENT ANALYSIS

11.1. Vitamins, Minerals, and Supplements CDMO Market Overview by Company Size Segment

11.1.1. Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Company Size

11.2. Small Companies

11.3. Mid-Sized Companies

11.4. Large Companies

CHAPTER NO. 12: VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – REGIONAL ANALYSIS

12.1. Vitamins, Minerals, and Supplements CDMO Market Overview by Region Segment

12.1.1. Global Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Region

12.1.2. Regions

12.1.3. Global Vitamins, Minerals, and Supplements CDMO Market Revenue By Region

12.1.4. Type

12.1.5. Global Vitamins, Minerals, and Supplements CDMO Market Revenue By Type

12.1.6. Dosage Form

12.1.7. Global Vitamins, Minerals, and Supplements CDMO Market Revenue By Dosage Form

12.1.8. Service Type

12.1.9. Global Vitamins, Minerals, and Supplements CDMO Market Revenue By Service Type

12.1.10. Company Size

12.1.11. Global Vitamins, Minerals, and Supplements CDMO Market Revenue By Company Size

CHAPTER NO. 13: NORTH AMERICA VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – COUNTRY ANALYSIS

13.1. North America Vitamins, Minerals, and Supplements CDMO Market Overview by Country Segment

13.1.1. North America Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Region

13.2. North America

13.2.1. North America Vitamins, Minerals, and Supplements CDMO Market Revenue By Country

13.2.2. Type

13.2.3. North America Vitamins, Minerals, and Supplements CDMO Market Revenue By Type

13.2.4. Dosage Form

13.2.5. North America Vitamins, Minerals, and Supplements CDMO Market Revenue By Dosage Form

13.2.6. Service Type

13.2.7. North America Vitamins, Minerals, and Supplements CDMO Market Revenue By Service Type

13.2.8. Company Size

13.2.9. North America Vitamins, Minerals, and Supplements CDMO Market Revenue By Company Size

13.3. U.S.

13.4. Canada

13.5. Mexico

CHAPTER NO. 14: EUROPE VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – COUNTRY ANALYSIS

14.1. Europe Vitamins, Minerals, and Supplements CDMO Market Overview by Country Segment

14.1.1. Europe Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Region

14.2. Europe

14.2.1. Europe Vitamins, Minerals, and Supplements CDMO Market Revenue By Country

14.2.2. Type

14.2.3. Europe Vitamins, Minerals, and Supplements CDMO Market Revenue By Type

14.2.4. Dosage Form

14.2.5. Europe Vitamins, Minerals, and Supplements CDMO Market Revenue By Dosage Form

14.2.6. Service Type

14.2.7. Europe Vitamins, Minerals, and Supplements CDMO Market Revenue By Service Type

14.2.8. Company Size

14.2.9. Europe Vitamins, Minerals, and Supplements CDMO Market Revenue By Company Size

14.3. UK

14.4. France

14.5. Germany

14.6. Italy

14.7. Spain

14.8. Russia

14.9. Rest of Europe

CHAPTER NO. 15: ASIA PACIFIC VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – COUNTRY ANALYSIS

15.1. Asia Pacific Vitamins, Minerals, and Supplements CDMO Market Overview by Country Segment

15.1.1. Asia Pacific Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Region

15.2. Asia Pacific

15.2.1. Asia Pacific Vitamins, Minerals, and Supplements CDMO Market Revenue By Country

15.2.2. Type

15.2.3. Asia Pacific Vitamins, Minerals, and Supplements CDMO Market Revenue By Type

15.2.4. Dosage Form

15.2.5. Asia Pacific Vitamins, Minerals, and Supplements CDMO Market Revenue By Dosage Form

15.2.6. Service Type

15.2.7. Asia Pacific Vitamins, Minerals, and Supplements CDMO Market Revenue By Service Type

15.2.8. Company Size

15.2.9. Asia Pacific Vitamins, Minerals, and Supplements CDMO Market Revenue By Company Size

15.3. China

15.4. Japan

15.5. South Korea

15.6. India

15.7. Australia

15.8. Southeast Asia

15.9. Rest of Asia Pacific

CHAPTER NO. 16: LATIN AMERICA VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – COUNTRY ANALYSIS

16.1. Latin America Vitamins, Minerals, and Supplements CDMO Market Overview by Country Segment

16.1.1. Latin America Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Region

16.2. Latin America

16.2.1. Latin America Vitamins, Minerals, and Supplements CDMO Market Revenue By Country

16.2.2. Type

16.2.3. Latin America Vitamins, Minerals, and Supplements CDMO Market Revenue By Type

16.2.4. Dosage Form

16.2.5. Latin America Vitamins, Minerals, and Supplements CDMO Market Revenue By Dosage Form

16.2.6. Service Type

16.2.7. Latin America Vitamins, Minerals, and Supplements CDMO Market Revenue By Service Type

16.2.8. Company Size

16.2.9. Latin America Vitamins, Minerals, and Supplements CDMO Market Revenue By Company Size

16.3. Brazil

16.4. Argentina

16.5. Rest of Latin America

CHAPTER NO. 17: MIDDLE EAST VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – COUNTRY ANALYSIS

17.1. Middle East Vitamins, Minerals, and Supplements CDMO Market Overview by Country Segment

17.1.1. Middle East Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Region

17.2. Middle East

17.2.1. Middle East Vitamins, Minerals, and Supplements CDMO Market Revenue By Country

17.2.2. Type

17.2.3. Middle East Vitamins, Minerals, and Supplements CDMO Market Revenue By Type

17.2.4. Dosage Form

17.2.5. Middle East Vitamins, Minerals, and Supplements CDMO Market Revenue By Dosage Form

17.2.6. Service Type

17.2.7. Middle East Vitamins, Minerals, and Supplements CDMO Market Revenue By Service Type

17.2.8. Company Size

17.2.9. Middle East Vitamins, Minerals, and Supplements CDMO Market Revenue By Company Size

17.3. GCC Countries

17.4. Israel

17.5. Turkey

17.6. Rest of Middle East

CHAPTER NO. 18: AFRICA VITAMINS, MINERALS, AND SUPPLEMENTS CDMO MARKET – COUNTRY ANALYSIS

18.1. Africa Vitamins, Minerals, and Supplements CDMO Market Overview by Country Segment

18.1.1. Africa Vitamins, Minerals, and Supplements CDMO Market Revenue Share By Region

18.2. Africa

18.2.1. Africa Vitamins, Minerals, and Supplements CDMO Market Revenue By Country

18.2.2. Type

18.2.3. Africa Vitamins, Minerals, and Supplements CDMO Market Revenue By Type

18.2.4. Dosage Form

18.2.5. Africa Vitamins, Minerals, and Supplements CDMO Market Revenue By Dosage Form

18.2.6. Service Type

18.2.7. Africa Vitamins, Minerals, and Supplements CDMO Market Revenue By Service Type

18.2.8. Company Size

18.2.9. Africa Vitamins, Minerals, and Supplements CDMO Market Revenue By Company Size

18.3. South Africa

18.4. Egypt

18.5. Rest of Africa

CHAPTER NO. 19: COMPANY PROFILES

19.1. Catalent Inc.

19.1.1. Company Overview

19.1.2. Product Portfolio

19.1.3. Financial Overview

19.1.4. Recent Developments

19.1.5. Growth Strategy

19.1.6. SWOT Analysis

19.2. Lonza Group AG

19.3. Aenova Group

19.4. NutraScience Labs

19.5. CAPTEK Softgel International Inc.

19.6. Alkemist Labs

19.7. Ashland Global Holdings

19.8. Company 8

19.9. Company 9

19.10. Company 10

Frequently Asked Questions

What is the current size of the Vitamins, Minerals, and Supplements CDMO Market?

The Vitamins, Minerals, and Supplements CDMO Market was valued at USD 38,800.18 million in 2024 and is projected to reach USD 76,410.24 million by 2032, growing at a CAGR of 8.23% during the forecast period.

What factors are driving the growth of the Vitamins, Minerals, and Supplements CDMO Market?

What factors are driving the growth of the Vitamins, Minerals, and Supplements CDMO Market?

What are some challenges faced by the Vitamins, Minerals, and Supplements CDMO Market?

Challenges include regulatory complexity across regions, supply chain disruptions, and fluctuating raw material prices impacting operations.

Who are the major players in the Vitamins, Minerals, and Supplements CDMO Market?

Major players include Catalent Inc., Lonza, Aenova Group, NutraScience Labs, and CAPTEK Softgel International Inc.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Reviewed By
Gunakesh Parmar

Research Consultant

With over 15 years of dedicated experience in market research since 2009, specializes in delivering actionable insights from data.

View Profile

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$12699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –